Serac Healthcare
Develops molecular imaging agents for clinicians treating endometriosis, interstitial lung disease and inflammatory arthritis
Highlights
- New on EvolcAdded 2026-11-15
About Serac Healthcare
Serac Healthcare is developing 99mTc-maraciclatide, a molecular imaging agent for endometriosis, interstitial lung disease and inflammatory arthritis. The imaging approach is being investigated to help clinicians assess disease activity and distinguish inflammation from fibrosis.
The company works with academic partners at King’s College London, the University of Leeds and the University of Oxford. Serac Healthcare Ltd was founded in 2017 and is registered in London, United Kingdom.
Product: Develops 99mTc-maraciclatide, a molecular imaging agent being investigated for several inflammatory conditions.
Jobs at Serac Healthcare
More biotech & pharma companies
Seren Plus
Wholesale supplier of prescription medicines and aesthetic products to pharmacies and clinics across the UKShafi Consultancy
Clinical trial statistical programming and data services for pharmaceutical companies and contract research organizationsNew on EvolcSiinovia (UK)
Develops and distributes niche generic and value-added medicines for healthcare markets and pharmaceutical partnersNew on EvolcSimplex Molecular
Molecular biology R&D, assay development and testing for research teams and businessesYoung companyNew on EvolcSisaf
RNA drug-delivery platform licensed to pharma partners, with a research reagent for labs plannedSitala Bio
Develops medicines targeting harmful inflammation for patients with neurodegenerative and inflammatory diseases
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- HotjarMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinitialization/configuration expression
- Integration code on pageinitialization/configuration expression
- Integration code on pageinitialization/configuration expression
Content management
- ElementorHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- LiteSpeedHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Privacy & consent
- CookieYesHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.